Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - STOCK-BASED COMPENSATION
Stock-based Compensation HALO - Halozyme Therapeutics, Inc.
36.6 M
LAST VALUE
32.62%
2 YEAR CAGR
0.51%
5 YEAR CAGR
14.40%
10 YEAR CAGR